Table 1 Patients’ characteristics and intra-operative variables
Variable | Volatile group (n = 65) | TIVA group (n = 67) | P value |
|---|---|---|---|
Age (year) | 64.6 ± 10.4 | 61.5 ± 9.0 | 0.068 |
Male sex | 37 (57%) | 29 (43%) | 0.117 |
Body mass index (kg/m2) | 23.2 ± 2.9 | 24.0 ± 2.8 | 0.108 |
ASA physical status | 0.688 | ||
I/II/III | 9 (14%)/39 (60%)/17 (26%) | 8 (12%)/45 (67%)/14 (21%) | |
Co-morbidities | |||
Hypertension | 27 (42%) | 18 (27%) | 0.075 |
Diabetes mellitus | 13 (20%) | 8 (12%) | 0.206 |
Type of operation | 0.834 | ||
Robotic/Laparoscopic | 26 (40%)/39 (60%) | 28 (42%)/39 (58%) | |
Type of gastrectomy | 0.420 | ||
Subtotal/Total/Proximal subtotal | 51 (79%)/12 (18%)/2 (3%) | 58 (87%)/7 (10%)/2 (3%) | |
Type of reconstruction | 0.091 | ||
Billoth I | 36 (55%) | 40 (60%) | |
Billoth II | 8 (12%) | 15 (22%) | |
Double tract | 3 (5%) | 4 (6%) | |
Roux-en-Y | 18 (28%) | 8 (12%) | |
Extent of lymph node dissection | 0.383 | ||
D1/D2 | 43 (66%)/22 (34%) | 49 (73%)/18 (27%) | |
TNM stage | 0.788 | ||
I/II/III/IV | 41 (63%)/14 (21%)/7 (11%)/3 (5%) | 47 (70%)/12 (18%)/4 (6%)/4 (6%) | |
Intra-operative variables | |||
Pneumoperitoneum time (min) | 151 ± 42 | 149 ± 47 | 0.769 |
Operation time (min) | 183 ± 43 | 182 ± 49 | 0.923 |
Anesthesia time (min) | 214 ± 44 | 213 ± 48 | 0.938 |
Crystalloid intake (mL) | 1254 ± 413 | 1331 ± 436 | 0.300 |
Colloid intake (mL) | 368 ± 284 | 321 ± 253 | 0.319 |
Blood loss (mL) | 69 ± 65 | 68 ± 90 | 0.936 |
Urine output (mL) | 191 ± 98 | 181 ± 112 | 0.590 |
Remifentanil dose (μg) | 940 ± 330 | 1294 ± 464 | < 0.001 |
Ephedrine dose (mg) | 6.8 ± 5.7 | 3.4 ± 4.9 | < 0.001 |
Phenylephrine dose (μg) | 1522 ± 2026 | 411 ± 1008 | < 0.001 |
